What Is Lisdexamfetamine (Vyvanse)?

What is Lisdexamfetamine (Vyvanse)?
This post was written with Consensus AI Academic Search Engine - please read our Disclaimer at the end of this article. Lisdexamfetamine dimesylate, commonly known by its brand name Vyvanse, is a prodrug of dextroamphetamine. It is primarily used in the treatment of attention-deficit/hyperactivity disorder (ADHD) and has also been approved for the treatment of moderate to severe binge eating disorder (BED) in adults. This article explores the pharmacology, efficacy, safety, and various applications of lisdexamfetamine.
Uses of Lisdexamfetamine (Vyvanse)
Efficacy in ADHD
Lisdexamfetamine has been shown to be effective in reducing the symptoms of ADHD in both children and adults. Clinical trials have demonstrated significant improvements in ADHD rating scale scores, with a duration of action lasting approximately 12 hours, making it suitable for once-daily dosing1 10. The drug has also been found to improve quality of life and performance in adults with ADHD, as measured by various self-reported scales8.
Efficacy in Binge Eating Disorder
Lisdexamfetamine is the first drug approved by the FDA for the treatment of moderate to severe BED in adults. Clinical trials have shown that it significantly reduces the number of binge eating days per week compared to placebo. Long-term studies have also indicated that it reduces the risk of BED relapse2 9.
Safety and Tolerability
The safety profile of lisdexamfetamine is similar to that of other stimulant medications. Common treatment-emergent adverse events (TEAEs) include decreased appetite, dry mouth, headache, and insomnia. Most TEAEs are mild to moderate in severity1 2. However, there have been rare reports of more severe side effects, such as bilateral acute angle closure in pediatric patients7.
Unique Applications
Lisdexamfetamine has been explored for various off-label uses. For instance, it has shown promise in treating attention deficits resulting from traumatic brain injury (TBI)4. Additionally, it has been reported to improve spatial working memory and reduce adiposity in animal studies5. A unique case study also highlighted its potential in treating neurogenic anejaculation, a rare cause of male infertility6.
Abuse Potential
One of the advantages of lisdexamfetamine over immediate-release amphetamines is its lower potential for abuse. This is attributed to its prodrug nature, which results in a slower onset of action and lower "drug liking" scores in drug-experienced individuals3. Learn more with Consensus: [button icon="โฌ" text="Does Lisdexamfetamine (Vyvanse) have a lower potential for abuse compared to immediate-release amphetamines?"][/button] [button icon="๐จโโ๏ธ" text="Is Lisdexamfetamine (Vyvanse) approved by the FDA for the treatment of binge eating disorder (BED)?"][/button]
Adverse Effects of Lisdexamfetamine (Vyvanse)
Decreased Appetite and Weight Loss Decreased appetite is a common side effect, reported by 25-39% of patients in various studies1 2 5 9. Weight loss and reduced gains in weight, height, and body mass index (BMI) have been observed in children and adolescents1 9. Insomnia Insomnia is frequently reported, affecting 11-19% of patients1 2 5 6 9. Headache and Dry Mouth Headache and dry mouth are also common, with incidences greater than 10%2 5 6. Cardiovascular Effects Small mean increases in blood pressure and pulse rate have been noted1. Visual Disorders Rare cases of visual disorders, such as accommodation disturbance and blurry vision, have been reported in pediatric patients3. Other Common Adverse Effects Other frequently reported side effects include dry eyes, mydriasis, and accommodation disturbance3. Additional side effects include anxiety and decreased mesenteric, renal, and epididymal adiposity in animal studies8. Potential for Abuse Although lisdexamfetamine has a lower potential for abuse compared to other stimulants, concerns about its abuse potential remain4 5. Serious Adverse Effects Serious adverse effects such as addiction, myocardial infarction, stroke, and death are not commonly highlighted in educational materials but are significant concerns7. Learn more with Consensus: [button icon="๐" text="What are the adverse effects of Lisdexamfetamine (Vyvanse)?"][/button] [button icon="๐ก" text="Is there a potential for abuse associated with Lisdexamfetamine (Vyvanse)?"][/button]
How has Lisdexamfetamine (Vyvanse) Improved Patient Outcomes?
Improvement in ADHD Symptoms and Quality of Life LDX significantly improves ADHD symptoms and overall quality of life in children, adolescents, and adults, showing superior efficacy compared to placebo and other treatments like atomoxetine and OROS-MPH1 3 4 7 9 10. Enhanced performance in daily activities, work, school, and relationships has been reported, along with improvements in general well-being and reduced interference from ADHD symptoms1 3 9. Sustained Attention and Cognitive Function LDX has shown positive effects on sustained attention, working memory, response speed stability, and executive functioning in both ADHD and TBI-related attention deficits2 8 9. Improvements in reading performance, particularly reading rate, have been observed in children with ADHD8. Safety and Tolerability The safety profile of LDX is consistent with other long-acting stimulants, with common side effects including decreased appetite, dry mouth, headache, and insomnia. Most adverse events are mild to moderate in severity1 3 4 6 7. LDX has a lower potential for abuse compared to short-acting stimulants, making it a safer option for long-term use4 7. Effectiveness in Binge Eating Disorder (BED) LDX is effective in reducing binge eating days and the risk of BED relapse, with a tolerability profile similar to that observed in ADHD patients6. Unique Applications LDX has been successfully used off-label for treating neurogenic anejaculation, demonstrating its potential in addressing rare conditions5. Learn more with Consensus: [button icon="๐" text="How has Lisdexamfetamine (Vyvanse) improved patient outcomes?"][/button]
Lisdexamfetamine (Vyvanse) Pharmacology and Mechanism of Action
Lisdexamfetamine is a prodrug, meaning it is inactive until metabolized in the body. Upon ingestion, it is converted to dextroamphetamine and l-lysine. The dextroamphetamine component is responsible for its therapeutic effects, which include increased attention and decreased impulsivity and hyperactivity in patients with ADHD3 10. Learn more with Consensus: [button icon="๐ก" text="What is Lisdexamfetamine (Vyvanse) mechanism of action?"][/button]
Common Complaints Associated with Lisdexamfetamine (Vyvanse) Use
Decreased Appetite and Insomnia Decreased appetite is reported by 25-39% of patients, and insomnia by 11-19% in both short-term and long-term studies1. Growth Concerns in Children and Adolescents Gains in weight, height, and body mass index are smaller in children and adolescents receiving LDX compared to placebo controls or untreated norms1. Cardiovascular Effects Small mean increases in blood pressure and pulse rate have been observed in patients receiving LDX1. Severe Adverse Reactions A rare case of bilateral acute angle closure in a pediatric patient was reported, which resolved upon discontinuation of LDX4. A case of serotonin syndrome in a 6-year-old girl following accidental ingestion of LDX, treated with dexmedetomidine due to severe agitation and neuromuscular hyperactivity2. Mild Anxiety Reaction In a controlled trial, one child withdrew due to a mild anxiety reaction while on LDX3. Learn more with Consensus: [button icon="๐ง๐ผ" text="How does Lisdexamfetamine (Vyvanse) affect growth in children and adolescents?"][/button] [button icon="๐" text="Does Lisdexamfetamine (Vyvanse) cause decreased appetite in a significant percentage of patients?"][/button]
Disclaimer
The content presented in this blog is generated by Consensus, an AI-powered academic search engine, and is based on publicly available scientific literature. While every effort is made to provide accurate, up-to-date, and well-researched information, the content is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any decisions regarding medical conditions, treatments, or medications. The AI system's analysis may not cover all perspectives, emerging research, or individual cases, and it is not a substitute for professional expertise. Neither the blog publisher nor the developers of the AI-powered search engine are responsible for any actions taken based on the information provided in this content. Use of this information is at your own risk. Citations to the original scientific studies are included for reference, but these studies should be reviewed in full and interpreted with the guidance of a healthcare or research professional. If you are experiencing a medical emergency, please seek immediate attention from a healthcare provider.
Start searching for free in Consensus!
Consensus searches through 220M+ peer reviewed research papers and provides you the best insights from them. Helping you find better papers, faster.

Sign Up